Showing results (1181-1190 of 1,344) with videos related to
Sort By:
Pageof 135
The Pharmacogenomics Journal|March 3, 2010
Single nucleotide polymorphisms in genes that are associated with a modified response to statin therapy: the Rotterdam StudyC E de Keyser, M Eijgelsheim, A Hofman, et al.The Pharmacogenomics Journal|March 3, 2010
BDNF Val66Met genotype and 6-month remission rates in late-life depressionW D Taylor, D R McQuoid, A Ashley-Koch, et al.The Pharmacogenomics Journal|March 3, 2010
Association study of MDR1 and 5-HT2C genetic polymorphisms and antipsychotic-induced metabolic disturbances in female patients with schizophreniaM R Kuzman, V Medved, N Bozina, et al.The Pharmacogenomics Journal|March 10, 2010
Polymorphisms in cytochromes P450 2C8 and 3A5 are associated with paclitaxel neurotoxicityS Leskelä, C Jara, L J Leandro-García, et al.The Pharmacogenomics Journal|December 24, 2009
A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's diseaseA D Roses, M W Lutz, H Amrine-Madsen, et al.The Pharmacogenomics Journal|December 30, 2009
A pharmacogenetic study of docetaxel and thalidomide in patients with castration-resistant prostate cancer using the DMET genotyping platformJ F Deeken, T Cormier, D K Price, et al.The Pharmacogenomics Journal|December 30, 2009
Cyclooxygenases-1 and -2 differentially modulate leukocyte recruitment into the inflamed brainS-H Choi, S Aid, U Choi, et al.The Pharmacogenomics Journal|November 30, 2005
(AAT)n repeat in the cannabinoid receptor gene (CNR1): association with cocaine addiction in an African-Caribbean populationN Ballon, S Leroy, C Roy, et al.The Pharmacogenomics Journal|November 30, 2005
Sequence diversity and haplotype structure at the human CYP3A clusterE E Thompson, H Kuttab-Boulos, L Yang, et al.The Pharmacogenomics Journal|November 30, 2005
Pharmacologic analysis of non-synonymous coding h5-HT2A SNPs reveals alterations in atypical antipsychotic and agonist efficaciesM A Davies, V Setola, R T Strachan, et al.Pageof 135